Mobile app to help teens and young adults with cancer manage stress
Pilot Trial Testing Mobile Health Psychosocial Intervention for Adolescents and Young Adults With Cancer
NA · Seattle Children's Hospital · NCT05842902
This study tests a mobile app that helps teens and young adults with cancer manage stress and improve their mental health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 12 Years to 25 Years |
| Sex | All |
| Sponsor | Seattle Children's Hospital (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT05842902 on ClinicalTrials.gov |
What this trial studies
This pilot trial aims to evaluate the feasibility and acceptability of a mobile app called mPRISM, designed to assist adolescents and young adults with cancer in managing psychosocial symptoms. The app incorporates evidence-based strategies for stress management, goal-setting, and mindfulness. Participants will be randomly assigned to either receive the app immediately or be placed on a waitlist, allowing for a comparison of outcomes. The study focuses on improving quality of life and mental health among this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are adolescents and young adults aged 12-25 who have been diagnosed with a new malignancy and are undergoing chemotherapy or radiation therapy.
Not a fit: Patients with a cancer diagnosis older than 12 months or those receiving only surgical treatment may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this app could significantly enhance the mental health and quality of life for young cancer patients.
How similar studies have performed: While mobile health interventions for psychosocial support are emerging, this specific approach using the mPRISM app is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 12-25 years * Diagnosis of new malignancy within 12 months of enrollment treated with chemotherapy and/or radiation therapy at Seattle Children's Hospital (SCH) * Patient able to speak/read/write English or Spanish language * Cognitively able to participate in mHealth psychosocial intervention and interactive interviews Exclusion Criteria: * Patient refusal to participate (any age), or parental refusal to participate for patients less than 18 years of age * Patients with diagnosis of malignancy \>12 months * Patients with relapsed, recurrent, or refractory disease * Patient without chemotherapy and/or radiation therapy as part of cancer treatment (e.g., surgical resection only patients are not-eligible) * Cognitively or physically unable to participate in mHealth psychosocial intervention and surveys
Where this trial is running
Seattle, Washington
- Seattle Children's Hospital — Seattle, Washington, United States (RECRUITING)
Study contacts
- Study coordinator: Nancy Lau, PhD
- Email: nancy.lau@seattlechildrens.org
- Phone: 206-884-0569
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Mobile health, Quality of life, Adolescent, Young Adult, Psychosocial factors